Addition of recombinant NRG1 to the NE SCLC cell lines H82 and H146 supported a role of NRG1 as ligand and activator of ERBB pathway in SCLC, inducing phosphorylation of ERK and AKT (Fig. S8C). Here, AKT1 is linked to small cell lung carcinoma.